Long non-coding RNA expression profiling following treatment with resveratrol to improve insulin resistance

Shu,Linyi; Hou,Guangsen; Zhao,Hang; Huang,Wenli; Song,Guangyao; Ma,Huijuan

doi:10.3892/mmr.2020.11221

Long non-coding RNA expression profiling following treatment with resveratrol to improve insulin resistance

Authors:
- Linyi Shu
- Guangsen Hou
- Hang Zhao
- Wenli Huang
- Guangyao Song
- Huijuan Ma
View Affiliations

Affiliations: Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China, Endocrinology Department, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China
Published online on: June 11, 2020 https://doi.org/10.3892/mmr.2020.11221
Pages: 1303-1316
Copyright: © Shu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Resveratrol (RSV) and long non‑coding RNAs (lncRNAs) play a role in the treatment of diabetes; however, the mechanism by which resveratrol regulates insulin resistance via lncRNAs is currently unknown. The present study aimed to determine the lncRNA expression level profile in mice following resveratrol treatment to improve insulin resistance using high‑throughput sequencing technology. C57BL/6J mice were fed a high‑fat diet for 8 weeks to develop an insulin resistance model, followed by treatment with or without RSV for 6 weeks before high‑throughput sequencing. Following RSV treatment, 28 and 30 lncRNAs were up‑ and downregulated, respectively; eight lncRNAs were randomly selected and evaluated using reverse transcription‑quantitative PCR, which showed results consistent with the sequencing analysis. Pathway analysis demonstrated that the insulin signaling pathway enrichment score was the highest, and identified two lncRNAs, NONMMUT058999.2 and NONMMUT051901.2, consistent with the protein‑encoding genes SOCS3 and G6PC, respectively. Similar expression level patterns were observed for SOCS3 and G6PC, suggesting that RSV improves insulin resistance by modulating lncRNAs. RSV decreased the expression levels of SOCS3, FOXO1, G6PC and PEPCK in mice. The same results were observed following knockdown of NONMMUT058999.2 in cells. The present study provides a new biomarker or intervention target for RSV in the treatment of diabetes, and a new perspective for understanding the hypoglycemic mechanism of RSV.

View Figures

View References

1	Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, Cavan D, Shaw JE and Markaroff LE: IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 128:40–50. 2017. View Article : Google Scholar : PubMed/NCBI
2	Akash MSH, Rehman K and Liaqat A: Tumor necrosis factor-alpha: Role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 119:105–110. 2018. View Article : Google Scholar : PubMed/NCBI
3	Rehman K, Akash MSH, Liaqat A, Kamal S, Qadir MI and Rasul A: Role of interleukin-6 in development of insulin resistance and type 2 diabetes mellitus. Crit Rev Eukaryot Gene Expr. 27:229–236. 2017. View Article : Google Scholar : PubMed/NCBI
4	Ku CR, Lee HJ, Kim SK, Lee EY, Lee MK and Lee EJ: Resveratrol prevents streptozotocin-induced diabetes by inhibiting the apoptosis of pancreatic β-cell and the cleavage of poly (ADP-ribose) polymerase. Endocr J. 59:103–109. 2012. View Article : Google Scholar : PubMed/NCBI
5	Li Q, Yue Y, Chen L, Xu C, Wang Y, Du L, Xue X, Liu Q, Wang Y and Fan F: Resveratrol sensitizes carfilzomib-induced apoptosis via promoting oxidative stress in multiple myeloma cells. Front Pharmacol. 9:3342018. View Article : Google Scholar : PubMed/NCBI
6	Zhu X, Wu C, Qiu S, Yuan X and Li L: Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: Systematic review and meta-analysis. Nutr Metab (Lond). 14:602017. View Article : Google Scholar : PubMed/NCBI
7	Abbasi Oshaghi E, Goodarzi MT, Higgins V and Adeli K: Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action. Crit Rev Clin Lab Sci. 54:267–293. 2017. View Article : Google Scholar : PubMed/NCBI
8	Zhao H, Shu L, Huang W, Song G and Ma H: Resveratrol affects hepatic gluconeogenesis via histone deacetylase 4. Diabetes Metab Syndr Obes. 12:401–411. 2019. View Article : Google Scholar : PubMed/NCBI
9	Hang Z, Yunjia Z, Linyi S, Guangyao S and Huijuan M: Resveratrol reduces liver endoplasmic reticulum stress and improves insulin sensitivity in vivo and in vitro. Drug Des Dev Ther. 13:1473–1485. 2019. View Article : Google Scholar
10	Wang X, Chang X, Zhang P, Fan L, Zhou T and Sun K: Aberrant expression of long non-coding RNAs in newly diagnosed type 2 diabetes indicates potential roles in chronic inflammation and insulin resistance. Cell Physiol Biochem. 43:2367–2378. 2017. View Article : Google Scholar : PubMed/NCBI
11	Gao Y, Wu F, Zhou J, Yan L, Jurczak MJ, Lee HY, Yang L, Mueller M, Zhou XB, Dandolo L, et al: The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells. Nucleic Acids Res. 42:13799–13811. 2014. View Article : Google Scholar : PubMed/NCBI
12	Shu L, Zhao H, Huang W, Hou G, Song G and Ma H: Resveratrol Upregulates mmu-miR-363-3p via the PI3K-Akt pathway to improve insulin resistance induced by a high-fat diet in mice. Diabetes Metab Syndr Obes. 13:391–403. 2020. View Article : Google Scholar : PubMed/NCBI
13	Buchfink B, Xie C and Huson DH: Fast and sensitive protein alignment using DIAMOND. Nat Methods. 12:59–60. 2015. View Article : Google Scholar : PubMed/NCBI
14	Robinson MD, McCarthy DJ and Smyth GK: edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 26:139–140. 2010. View Article : Google Scholar : PubMed/NCBI
15	Zou Q, Mao Y, Hu L, Wu Y and Ji Z: miRClassify: An advanced web server for miRNA family classification and annotation. Comput Biol Med. 45:157–160. 2014. View Article : Google Scholar : PubMed/NCBI
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
17	Zhang H, Ge Z, Tang S, Meng R, Bi Y and Zhu D: Erythropoietin ameliorates PA-induced insulin resistance through the IRS/AKT/FOXO1 and GSK-3β signaling pathway, and inhibits the inflammatory response in HepG2 cells. Mol Med Rep. 16:2295–2301. 2017. View Article : Google Scholar : PubMed/NCBI
18	Shu L, Hou G, Zhao H, Huang W, Song G and Ma H: Resveratrol improves high-fat diet-induced insulin resistance in mice by downregulating the lncRNA NONMMUT008655.2. Am J Transl Res. 12:1–18. 2020.PubMed/NCBI
19	Li B and Dewey C: RSEM: Accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 12:3232011. View Article : Google Scholar : PubMed/NCBI
20	Grabherr MG, Haas BJ, Yassour M, Levin JZ, Thompson DA, Amit I, Adiconis X, Fan L, Raychowdhury R, Zeng Q, et al: Trinity: Reconstructing a full-length transcriptome without a genome from RNA-Seq data. Nat Biotechnol. 29:644–652. 2011. View Article : Google Scholar : PubMed/NCBI
21	Brasnyó P, Molnár GA, Mohás M, Markó L, Laczy B, Cseh J, Mikolás E, Szijártó IA, Mérei A, Halmai R, et al: Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr. 106:383–389. 2011. View Article : Google Scholar : PubMed/NCBI
22	Thiel G and Rössler OG: Resveratrol regulates gene transcription via activation of stimulus-responsive transcription factors. Pharmacol Res. 117:166–176. 2017. View Article : Google Scholar : PubMed/NCBI
23	Rezaei Farimani A, Goodarzi MT, Saidijam M, Yadegarazari R, Zarei S and Asadi S: Effect of resveratrol on SNARE proteins expression and insulin resistance in skeletal muscle of diabetic rats. Iran J Basic Med Sci. 22:1408–1414. 2019.PubMed/NCBI
24	Kim J, Bilder D and Neufeld TP: Mechanical stress regulates insulin sensitivity through integrin-dependent control of insulin receptor localization. Genes Dev. 32:156–164. 2018. View Article : Google Scholar : PubMed/NCBI
25	Hatting M, Tavares CDJ, Sharabi K, Rines AK and Puigserver P: Insulin regulation of gluconeogenesis. Ann N Y Acad Sci. 1411:21–35. 2018. View Article : Google Scholar : PubMed/NCBI
26	Langlet F, Haeusler RA, Lindén D, Ericson E, Norris T, Johansson A, Cook JR, Aizawa K, Wang L, Buettner C and Accili D: Selective inhibition of FOXO1 activator/repressor balance modulates hepatic glucose handling. Cell. 171:824–835.e18. 2017. View Article : Google Scholar : PubMed/NCBI
27	McCurdy CE, Schenk S, Holliday MJ, Philip A, Houck JA, Patsouris D, MacLean PS, Majka SM, Klemm DJ and Friedman JE: Attenuated Pik3r1 expression prevents insulin resistance and adipose tissue macrophage accumulation in diet-induced obese mice. Diabetes. 61:2495–505. 2012. View Article : Google Scholar : PubMed/NCBI
28	Ma Z, Gong Y, Patel V, Karner CM, Fischer E, Hiesberger T, Carroll TJ, Pontoglio M and Igarashi P: Mutations of HNF-1beta inhibit epithelial morphogenesis through dysregulation of SOCS-3. Proc Natl Acad Sci USA. 104:20386–20391. 2007. View Article : Google Scholar : PubMed/NCBI
29	Galic S, Sachithanandan N, Kay TW and Steinberg GR: Suppressor of cytokine signalling (SOCS) proteins as guardians of inflammatory responses critical for regulating insulin sensitivity. Biochem J. 461:177–188. 2014. View Article : Google Scholar : PubMed/NCBI
30	Fang S, Feng J, Zhang H, Li P, Zhang Y, Zeng Y, Cai Y, Lin X, Xue Y and Guan M: MiR-455 targeting SOCS3 improve liver lipid disorders in diabetic mice. Adipocyte. 9:179–188. 2020. View Article : Google Scholar : PubMed/NCBI
31	Pedroso JA, Buonfiglio DC, Cardinali LI, Furigo IC, Ramos-Lobo AM, Tirapegui J, Elias CF and Donato J Jr: Inactivation of SOCS3 in leptin receptor-expressing cells protects mice from diet-induced insulin resistance but does not prevent obesity. Mol Metab. 3:608–618. 2014. View Article : Google Scholar : PubMed/NCBI
32	Abo El-Nasr NME, Saleh DO, Mahmoud SS, Nofal SM, Abdelsalam RM, Safar MM and El-Abhar HS: Olmesartan attenuates type 2 diabetes-associated liver injury: Cross-talk of AGE/RAGE/JNK, STAT3/SCOS3 and RAS signaling pathways. Eur J Pharmacol. 874:1730102020. View Article : Google Scholar : PubMed/NCBI
33	Terán-Cabanillas E and Hernández J: Role of leptin and SOCS3 in inhibiting the type I interferon response during obesity. Inflammation. 40:58–67. 2017. View Article : Google Scholar : PubMed/NCBI
34	Qi X, Zhang DH, Wu N, Xiao JH, Wang X and Ma W: ceRNA in cancer: Possible functions and clinical implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
35	Dong C, Liu S, Li Y and Cui Y: Serum lncRNA HAND2-AS1 is downregulated in diabetic patients with chronic renal failure and ameliorates cell apoptosis. Diabetol Metab Syndr. 12:392020. View Article : Google Scholar : PubMed/NCBI
36	Sathishkumar C, Prabu P, Mohan V and Balasubramanyam M: Linking a role of lncRNAs (long non-coding RNAs) with insulin resistance, accelerated senescence, and inflammation in patients with type 2 diabetes. Hum Genomics. 12:412018. View Article : Google Scholar : PubMed/NCBI
37	Zhao H, Chen S, Gao K, Zhou Z, Wang C, Shen Z, Guo Y, Li Z, Wan Z, Liu C and Mei X: Resveratrol protects against spinal cord injury by activating autophagy and inhibiting apoptosis mediated by the SIRT1/AMPK signaling pathway. Neuroscience. 348:241–251. 2017. View Article : Google Scholar : PubMed/NCBI
38	González-Rodríguez Á, Santamaría B, Mas-Gutierrez JA, Rada P, Fernández-Millán E, Pardo V, Álvarez C, Cuadrado A, Ros M, Serrano M and Valverde AM: Resveratrol treatment restores peripheral insulin sensitivity in diabetic mice in a sirt1-independent manner. Mol Nutr Food Res. 59:1431–1442. 2015. View Article : Google Scholar : PubMed/NCBI
39	Guttman M and Rinn JL: Modular regulatory principles of large non-coding RNAs. Nature. 482:339–346. 2012. View Article : Google Scholar : PubMed/NCBI
40	Ren XY, Han YD and Lin Q: Long non-coding RNA MIR155HG knockdown suppresses cell proliferation, migration and invasion in NSCLC by upregulating TP53INP1 directly targeted by miR-155-3p and miR-155-5p. Eur Rev Med Pharmacol Sci. 24:4822–4835. 2020.PubMed/NCBI
41	Chen K, Ma Y, Wu S, Zhuang Y, Liu X, Lv L and Zhang G: Construction and analysis of a lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveals functional lncRNAs in diabetic cardiomyopathy. Mol Med Rep. 20:1393–1403. 2019.PubMed/NCBI